The Malaria P.f/P.v Antigen Rapid Test is a lateral flow immunoassay for the qualitative detection of Histidine-Rich Protein II (HRP-II) specific to Plasmodium falciparum (P.f) and Plasmodium lactate dehydrogenase (pLDH) specific to Plasmodium vivax (P.v) in human whole blood specimen. It is intended to be used by professionals as a screening test and provides a preliminary test result to aid in the diagnosis of infection with Malaria. For professional in vitro diagnostic use only.
Introduction Malaria is one of the most devastating infectious diseases of humans. It is problematic clinically and economically as it prevails in poorer countries and regions, strongly hindering socioeconomic development. The causative agents of malaria are unicellular protozoan parasites belonging to the genus Plasmodium. These parasites infect not only humans but also other vertebrates, from reptiles and birds to mammals. The Malaria P.f/P.v Antigen Rapid Test is a rapid lateral flow immunoassay for the qualitative detection of Histidine-Rich Protein II (HRP-II) specific to Plasmodium falciparum (P.f) and Plasmodium lactate dehydrogenase (pLDH) specific to Plasmodium vivax (P.v) in human whole blood and can give a result between 20-30 minutes by minimally skilled personnel without any laboratory equipment.
Product Features
Product Name:Malaria P.f/P.v Antigen Rapid Test
Sample Type:Whole Blood
Loading Volume:2 drops
Reaction Time:20-30 mins
Shelf Life:24 months
Storage:35.6-104°F (2-40℃)
Test Procedure The test should be operated at room temperature 59-86°F (15-30℃). 1. Allow the test cassette, specimen and buffer to reach room temperature before testing. 2. Remove the test cassette from the foil pouch and use it as soon as possible. 3. Place the test cassette on a flat and clean surface. Transfer the specimen by a pipette or a dropper: 4. Wait for the colored line(s) to appear and read the results between 20-30 minutes.
The Malaria P.f/Pan Antigen Rapid Test is a rapid lateral flow immunoassay for the qualitative detection of Histidine-Rich Protein II (HRP-II) specific to Plasmodium falciparum (P.f) and Plasmodium lactate dehydrogenase (pLDH) specific to Plasmodium species (Pan) in human whole blood specimen. It is intended to be used by professionals as a screening test and provides a preliminary test result to aid in the diagnosis of infection with Malaria. For professional in vitro diagnostic use only.
The Biotime Insulin Rapid Quantitative Test is intended to quantify the concentration of insulin in human serum, plasma, or whole blood samples on the Biotime FIA Analyzer (Semi-automatic/Automatic) by fluorescent immunoassay. -Fluorescence immunoassay For in vitro diagnostic use only. For professional use only.
FLI-600 is a fluorescent immunoassay system with 6 channels that uses blood and urine to measure the quantitative concentration of targeted analyte. Its automated test process enables to carry out multiple simultaneous tests for six different samples.
FSH Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Follicle-stimulating hormone (FSH) concentration in human serum and plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of reproductive hormones diseases.
HbA1c Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Glycated hemoglobin A1c (HbA1c) concentration in human whole blood that contains EDTA or without anticoagulants samples, mainly used for the supervising of long-term glycemic control in diabetic individuals and auxiliary diagnosis of diabetes and identify patients at risk of diabetes.
CLi-1600 semi-automated device which quantifies biomarkers for thyroid disease, inflammation, cardiac diseases, fertility, diabetes, bone metabolism, anemia, and health check by analyzing human serum, plasma and whole blood.
25(OH)-D is a prehormone that is produced in the liver by hydroxylation of vitamin D3 (cholecalciferol) by the enzyme cholecalciferol 25-hydroxylase. Physicians worldwide measure this metabolite to determine a patient's vitamin D status.
PROG Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Progesterone (PROG) concentration in human serum and plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of reproductive hormones diseases.